Almirall Highlights R&D Pipeline & Leadership in Dermatology
Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology, is participating in the 44th J.P. Morgan Healthcare Conference 2026, taking place from 12th to 14th January...
